21Shares 2x Long Sui ETF logo

21Shares 2x Long Sui ETF (TXXS)

Market Closed
10 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
20. 08
+1.06
+5.5468%
$
52.36M Market Cap
6.97% Div Yield
2,950 Volume
$ 19.02
Previous Close
Add Transaction
Day Range
19.76 20.14
Year Range
18.3 307
Want to track TXXS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TXXS closed today higher at $20.08, an increase of 5.5468% from yesterday's close, completing a monthly increase of 1.4401% or $0.29. Over the past 12 months, TXXS stock gained 8.6898%.
TXXS pays dividends to its shareholders, with the most recent payment made on Feb 26, 2026. The next estimated payment will be in 5 months ago on Feb 26, 2026 for a total of $0.0055.
The stock of the company had never split.
The company's stock is traded on one exchange.

TXXS Chart

21Shares 2x Long Sui ETF (TXXS) FAQ

What is the stock price today?

The current price is $20.08.

On which exchange is it traded?

21Shares 2x Long Sui ETF is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is TXXS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6.97%.

What is its market cap?

As of today, the market cap is 52.36M.

Has 21Shares 2x Long Sui ETF ever had a stock split?

No, there has never been a stock split.

21Shares 2x Long Sui ETF Profile

NASDAQ (NMS) Exchange
US Country

Overview

The Fund is strategically designed to primarily focus on generating substantial income by capitalizing on the trading and selling of options related to Hims & Hers Health, Inc. (NASDAQ HIMS). By leveraging financial instruments that aim to deliver double the daily performance of the underlying stock, the Fund seeks to achieve an ambitious investment objective of 200% of the income produced through options trading. Additionally, the Fund has a secondary aim to provide investors with exposure to the performance of leveraged exchange-traded funds specifically created for the Underlying Stock. While these objectives present exciting opportunities for growth, it is important to note that the Fund incorporates a cap on potential investment gains as well as downside protection measures that may influence the net income generated.

Products and Services

  • Options Trading on Hims & Hers Health, Inc.

    The primary offering of the Fund involves trading options on Hims & Hers Health, Inc. By strategically selling these options, the Fund aims to achieve a net income that is substantially greater than traditional investing methods, targeting a remarkable 200% return based on the performance of the options market.

  • Leveraged Exchange-Traded Funds (ETFs)

    To meet its dual objectives, the Fund uses specially structured leveraged ETFs that are intended to replicate 2 times (200%) the daily performance of Hims & Hers Health, Inc. This financial vehicle allows investors to engage with the underlying stock dynamically, providing increased opportunities for capital appreciation while also exposing them to heightened risk levels associated with leveraged trading.

  • Downside Protection Strategies

    In order to mitigate potential losses and stabilize income levels, the Fund integrates downside protection measures into its investment strategy. These strategies work to safeguard against adverse market conditions, which can influence the overall net income produced by the Fund’s activities in the options and ETF markets.

  • Income Generation Techniques

    The Fund employs a variety of income generation techniques, focusing heavily on options selling strategies. This approach aims to produce consistent cash flow while maximizing returns on investment through the leveraged structure. Investors can expect a well-thought-out method in managing income risks and the potential for attractive risk-adjusted returns.

Contact Information

Address: 205 Hudson Street, 7th Floor
Phone: 1-800-422-3554